New program aims to catch silent liver damage before It's too late

NCT ID NCT07031089

Recruiting now Prevention Sponsor: University Hospital, Grenoble Source: ClinicalTrials.gov ↗

Summary

This study is testing a new system to help family doctors find liver scarring (fibrosis) earlier in patients at risk from alcohol, obesity, or diabetes. It connects primary care clinics with a hospital to provide a special scan (Fibroscan) for patients with a high initial blood test score. The main goal is to see if patients with concerning scan results actually get the follow-up specialist care they need.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIVER FIBROSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Communauté Professionnelle Territoriale de Santé Sud Est Grenoblois
NOT_YET_RECRUITING

Grenoble, France

Contact Phone: •••-•••-•••• Email: •••••@•••••
Grenoble Alpes University Hospital
RECRUITING

Grenoble, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

LIVER FIBROSIS